価格表

在庫・価格 : 2026年04月06日 21時32分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-TRANCE/TNFSF11/RANK L, Mouse-Mono(12A668)
データシート※最新のデータシートでない場合があります
NB100-56512SS NOVノバス バイオロジカルス
Novus biologicals, LLC
0.025 mg ¥43,000
(未発注)
追加

在庫・価格 : 2026年04月06日 21時32分 現在

Anti-TRANCE/TNFSF11/RANK L, Mouse-Mono(12A668)

  • 商品コード:NB100-56512SS
  • メーカー:NOV
  • 包装:0.025mg
  • 価格: ¥43,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
Shin M et al
2011/01/01
Applications: PubMed
2 Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
Hu P et al
2011/01/01
Species: Human, Applications: IHC, ICC/IF PubMed
3 Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
Rubin J et al
2004/01/01
Applications: PubMed
4 Neidhart M et al. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann. Rheum. Dis. 2009 Aug;68(8):1334-9
Neidhart M et al
2009/01/01
Species: Human, Applications: IHC-P PubMed
5 Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
Parrula C et al
2009/01/01
Applications: Flow-CS PubMed
6 Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
Ghoreishi M et al
2009/01/01
Species: Mouse, Applications: IHC-P PubMed
7 Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
Fiumara P et al
2001/01/01
Applications: PubMed
8 Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
Sandra F et al
2005/01/01
Applications: ELISA PubMed
9 Mine Y et al. Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells. Cell Biol. Int. 2014 May;38(5):655-62
Mine Y et al
2014/01/01
Species: Mouse, Applications: WB PubMed
10 Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. J. Vasc. Res. 2014;51(2):118-31
Callegari A et al
2014/01/01
Species: Mouse, Applications: IHC-P PubMed
11 Niida S et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J. Biol. Chem. 2004 Feb;279(7):5752-6
Niida S et al
2004/01/01
Applications: PubMed
12 Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
Pearse RN et al
2001/01/01
Applications: PubMed
13 Gambichler T et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br. J. Dermatol. 2013 Dec;169(6):1288-94
Gambichler T et al
2013/01/01
Species: Human, Applications: IHC-P PubMed
14 Hu P et al. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. PLoS ONE 2013;8(9):e73081
Hu P et al
2013/01/01
Species: Human, Applications: PubMed
15 Yin Y et al. Lesional infiltration of receptor activator of nuclear factor-κB ligand(+) cells in experimental autoimmune neuritis rats. Neurol Sci 2012 Jul;
Yin Y et al
2012/01/01
Species: Rat, Applications: IHC PubMed
16 Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
Kikuchi T et al
2001/01/01
Applications: PubMed
17 Kim RY et al. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterials 2014 Feb;35(6):1869-81
Kim RY et al
2014/01/01
Species: Rat, Applications: IHC-P PubMed
18 Boyce AM et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 2012 Jul;27(7):1462-70
Boyce AM et al
2012/01/01
Species: Mouse, Applications: IHC-P PubMed
  • No.: 1
  • 文献情報:
    Shin M et al. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells. Carcinogenesis 2011 Nov;32(11):1634-40
    Shin M et al
    2011/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Hu P et al. Multiplexed quantum dot labeling of activated c-Met signaling in castration-resistant human prostate cancer. PLoS ONE 2011;6(12):e28670
    Hu P et al
    2011/01/01
  • 備考:
    Species: Human, Applications: IHC, ICC/IF
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Rubin J et al. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Prostate 2004 Jan;58(1):41-9
    Rubin J et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Neidhart M et al. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann. Rheum. Dis. 2009 Aug;68(8):1334-9
    Neidhart M et al
    2009/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Parrula C et al. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia. Vet. Pathol. 2009 Sep;46(5):1003-14
    Parrula C et al
    2009/01/01
  • 備考:
    Applications: Flow-CS
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Ghoreishi M et al. Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J. Immunol. 2009 May;182(10):6071-8
    Ghoreishi M et al
    2009/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Fiumara P et al. Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines. Blood 2001 Nov;98(9):2784-90
    Fiumara P et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Sandra F et al. Ameloblastoma induces osteoclastogenesis: a possible role of ameloblastoma in expanding in the bone. Oral Oncol. 2005 Jul;41(6):637-44
    Sandra F et al
    2005/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Mine Y et al. Involvement of ERK and p38 MAPK pathways on Interleukin-33-induced RANKL expression in osteoblastic cells. Cell Biol. Int. 2014 May;38(5):655-62
    Mine Y et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: WB
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Callegari A et al. Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6. J. Vasc. Res. 2014;51(2):118-31
    Callegari A et al
    2014/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Niida S et al. Gamma-glutamyltranspeptidase stimulates receptor activator of nuclear factor-kappaB ligand expression independent of its enzymatic activity and serves as a pathological bone-resorbing factor. J. Biol. Chem. 2004 Feb;279(7):5752-6
    Niida S et al
    2004/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Pearse RN et al. Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. Proc. Natl. Acad. Sci. U.S.A. 2001 Sep;98(20):11581-6
    Pearse RN et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Gambichler T et al. T regulatory cells and related immunoregulatory factors in polymorphic light eruption following ultraviolet A1 challenge. Br. J. Dermatol. 2013 Dec;169(6):1288-94
    Gambichler T et al
    2013/01/01
  • 備考:
    Species: Human, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hu P et al. Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study. PLoS ONE 2013;8(9):e73081
    Hu P et al
    2013/01/01
  • 備考:
    Species: Human, Applications:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Yin Y et al. Lesional infiltration of receptor activator of nuclear factor-κB ligand(+) cells in experimental autoimmune neuritis rats. Neurol Sci 2012 Jul;
    Yin Y et al
    2012/01/01
  • 備考:
    Species: Rat, Applications: IHC
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kikuchi T et al. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors. J. Immunol. 2001 Mar;166(5):3574-9
    Kikuchi T et al
    2001/01/01
  • 備考:
    Applications:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Kim RY et al. The effect of dose on rhBMP-2 signaling, delivered via collagen sponge, on osteoclast activation and in vivo bone resorption. Biomaterials 2014 Feb;35(6):1869-81
    Kim RY et al
    2014/01/01
  • 備考:
    Species: Rat, Applications: IHC-P
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Boyce AM et al. Denosumab treatment for fibrous dysplasia. J. Bone Miner. Res. 2012 Jul;27(7):1462-70
    Boyce AM et al
    2012/01/01
  • 備考:
    Species: Mouse, Applications: IHC-P
  • 参照:
    PubMed